drugset / Trial / NCT00566202
A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of JNJ-18038683 compared to escitalopram and placebo in patients with moderate to severe depression.
Timeline
- Start
- 2007-12
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Escitalopram | Small molecule | 20 mg | Oral |
| Subject | JNJ-18038683 | Small molecule | 10 mg | Oral |
| Subject | JNJ-18038683 | Small molecule | 20 mg | Oral |